Clinical Trials Browser

Phase 3 × Dalteparin × Classical hematology × Clear all

NCT05171075 2025-12-19

MAGNOLIA

Phase 3 Active not recruiting

Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Phase 3 Completed

1,046 enrolled 24 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Phase 3 Completed

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

Phase 3 Terminated

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Phase 3 Completed

CNSClassical hematology

Brain Neoplasms, Glioma, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism